Peter A Rittenhouse

Title: The Innovations of Peter A. Rittenhouse

Introduction

Peter A. Rittenhouse is a notable inventor based in Philadelphia, PA. He has made significant contributions to the field of biomedical research, particularly in the area of peptide-based therapies. His work has implications for understanding and treating various diseases related to corticotropin release inhibiting factor (CRIF).

Latest Patents

Rittenhouse holds a patent for a groundbreaking invention titled "Corticotropin release inhibiting factor and methods of using same for." This invention includes a substantially pure preparation of a peptide with CRIF activity, which comprises at least three contiguous amino acids found within the amino acid sequence positioned between the fourth and fifth thyrotropin releasing hormone (TRH) sequences on a prepro-TRH protein. The CRIF peptide also includes the fourth uncleaved TRH portion of prepro-TRH positioned at the amino terminus of CRIF. The patent encompasses compositions, methods of diagnosis, and methods for treating CRIF-related diseases.

Career Highlights

Peter A. Rittenhouse is affiliated with the University of Pennsylvania, where he conducts his research and development work. His innovative approach to peptide research has garnered attention in the scientific community. He has been recognized for his contributions to the understanding of CRIF and its potential therapeutic applications.

Collaborations

Rittenhouse has collaborated with esteemed colleagues such as Eva E. Redei and Fraser Aird. These partnerships have enhanced the scope and impact of his research, leading to advancements in the field.

Conclusion

Peter A. Rittenhouse's work exemplifies the intersection of innovation and biomedical research. His patent on corticotropin release inhibiting factor represents a significant step forward in the treatment of related diseases. His contributions continue to influence the scientific community and pave the way for future discoveries.